E LENV 4 mg (Lenvima 4 mg)
Generic Name: lenvatinib
Pill with imprint E LENV 4 mg is Red, Capsule-shape and has been identified as Lenvima 4 mg. It is supplied by Eisai Co., Ltd..
Lenvima is used in the treatment of hepatocellular carcinoma; endometrial cancer; thyroid cancer; renal cell carcinoma and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. Lenvima 4 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for E LENV 4 mg
Lenvima
- Generic Name
- lenvatinib
- Imprint
- E LENV 4 mg
- Strength
- 4 mg
- Color
- Red
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors, VEGF/VEGFR inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Eisai Co., Ltd.
- National Drug Code (NDC)
- 62856-0712
More about Lenvima (lenvatinib)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 1 Review
- Drug class: multikinase inhibitors
- FDA Approval History
Consumer resources
- Lenvima
- Lenvima (14 MG Daily Dose)
- Lenvima (18 MG Daily Dose)
- Lenvima (20 MG Daily Dose)
- Lenvima (24 MG Daily Dose)
- ... +2 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
